Emergent Retained Earnings from 2010 to 2024

EBS Stock

USD 10.12 0.01 0.1%

Emergent Biosolutions Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Emergent Biosolutions retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2004-12-31

Previous Quarter

-295.9 M

Current Value

-181.1 M

Quarterly Volatility

253.1 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 135.6 M, Interest Expense of 92.3 M or Total Revenue of 560.8 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.018 or PTB Ratio of 0.18. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.

Check out the analysis of Emergent Biosolutions Correlation against competitors.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Latest Emergent Biosolutions' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Emergent Biosolutions over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Emergent Biosolutions' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (21.8 M)

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Emergent Retained Earnings Regression Statistics

	Arithmetic Mean	386,129,467
	Geometric Mean	266,739,161
	Coefficient Of Variation	73.43
	Mean Deviation	218,233,689
	Median	337,074,000
	Standard Deviation	283,544,735
	Sample Variance	80397.6T
	Range	979.6M
	R-Value	0.02
	Mean Square Error	86534.1T
	R-Squared	0.0006
	Significance	0.93
	Slope	1,492,407
	Total Sum of Squares	1125566.6T

Emergent Retained Earnings History

	2024	-20.7 M
	2023	-21.8 M
	2022	734 M
	2021	957.8 M
	2019	421.8 M
	2018	367.3 M
	2017	337.1 M

Other Fundumenentals of Emergent Biosolutions

Retained Earnings Total Equity

Emergent Biosolutions Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Term Investments	Property Plant Equipment	Deferred Long Term Liab	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.65	0.51	0.6	0.62	0.65	0.92	0.64	0.42	0.7	0.69	0.72	0.88	0.78	0.72	0.75	-0.59	0.87	0.85	0.85	0.14	0.55	0.9	0.22	0.04
Total Stockholder Equity	0.95		0.43	0.55	0.44	0.53	0.46	0.79	0.55	0.26	0.51	0.49	0.74	0.8	0.63	0.63	0.64	-0.46	0.8	0.76	0.75	-0.02	0.44	0.81	0.39	0.14
Net Debt	0.65	0.43		-0.03	0.51	0.53	0.72	0.87	0.38	0.64	0.77	0.73	0.31	0.63	0.92	0.81	0.81	-0.77	0.71	0.72	0.79	0.3	0.43	0.77	-0.4	-0.54
Retained Earnings	0.51	0.55	-0.03		0.65	0.55	0.48	0.32	0.83	0.01	0.5	0.47	0.61	0.42	0.15	-0.03	0.14	-0.04	0.33	0.34	0.21	0.03	0.24	0.47	0.6	0.55
Accounts Payable	0.6	0.44	0.51	0.65		0.8	0.92	0.63	0.91	0.25	0.87	0.92	0.7	0.62	0.67	0.41	0.53	-0.44	0.7	0.63	0.64	0.09	0.59	0.65	0.25	-0.04
Net Receivables	0.62	0.53	0.53	0.55	0.8		0.88	0.6	0.7	-0.04	0.85	0.85	0.7	0.77	0.65	0.35	0.49	-0.25	0.65	0.76	0.62	-0.31	0.17	0.58	0.39	0.06
Good Will	0.65	0.46	0.72	0.48	0.92	0.88		0.74	0.79	0.28	0.98	0.98	0.62	0.73	0.79	0.49	0.63	-0.46	0.72	0.76	0.72	0.03	0.42	0.69	0.1	-0.13
Total Liab	0.92	0.79	0.87	0.32	0.63	0.6	0.74		0.61	0.59	0.78	0.74	0.62	0.84	0.92	0.86	0.87	-0.75	0.88	0.88	0.88	0.24	0.61	0.96	-0.04	-0.29
Total Current Assets	0.64	0.55	0.38	0.83	0.91	0.7	0.79	0.61		0.34	0.76	0.79	0.67	0.55	0.52	0.37	0.46	-0.44	0.64	0.54	0.56	0.19	0.58	0.69	0.28	0.1
Short Term Debt	0.42	0.26	0.64	0.01	0.25	-0.04	0.28	0.59	0.34		0.35	0.35	-0.07	0.07	0.49	0.63	0.47	-0.83	0.47	0.14	0.54	0.85	0.61	0.58	-0.7	-0.41
Intangible Assets	0.7	0.51	0.77	0.5	0.87	0.85	0.98	0.78	0.76	0.35		0.96	0.57	0.74	0.81	0.49	0.66	-0.49	0.7	0.77	0.71	0.11	0.36	0.76	0.06	-0.09
Common Stock	0.69	0.49	0.73	0.47	0.92	0.85	0.98	0.74	0.79	0.35	0.96		0.6	0.7	0.8	0.54	0.65	-0.55	0.79	0.72	0.78	0.12	0.51	0.7	0.06	-0.11
Current Deferred Revenue	0.72	0.74	0.31	0.61	0.7	0.7	0.62	0.62	0.67	-0.07	0.57	0.6		0.78	0.6	0.46	0.55	-0.27	0.71	0.77	0.59	-0.3	0.45	0.68	0.64	0.05
Long Term Debt	0.88	0.8	0.63	0.42	0.62	0.77	0.73	0.84	0.55	0.07	0.74	0.7	0.78		0.77	0.59	0.74	-0.35	0.76	0.98	0.72	-0.21	0.34	0.77	0.41	0.02
Short Term Investments	0.78	0.63	0.92	0.15	0.67	0.65	0.79	0.92	0.52	0.49	0.81	0.8	0.6	0.77		0.86	0.87	-0.77	0.88	0.85	0.89	0.11	0.56	0.88	-0.09	-0.49
Property Plant Equipment	0.72	0.63	0.81	-0.03	0.41	0.35	0.49	0.86	0.37	0.63	0.49	0.54	0.46	0.59	0.86		0.87	-0.91	0.87	0.68	0.89	0.22	0.69	0.8	-0.24	-0.63
Deferred Long Term Liab	0.75	0.64	0.81	0.14	0.53	0.49	0.63	0.87	0.46	0.47	0.66	0.65	0.55	0.74	0.87	0.87		-0.77	0.82	0.81	0.84	0.11	0.53	0.8	-0.06	-0.46
Treasury Stock	-0.59	-0.46	-0.77	-0.04	-0.44	-0.25	-0.46	-0.75	-0.44	-0.83	-0.49	-0.55	-0.27	-0.35	-0.77	-0.91	-0.77		-0.78	-0.45	-0.8	-0.53	-0.75	-0.74	0.45	0.61
Net Tangible Assets	0.87	0.8	0.71	0.33	0.7	0.65	0.72	0.88	0.64	0.47	0.7	0.79	0.71	0.76	0.88	0.87	0.82	-0.78		0.78	0.97	0.11	0.73	0.84	0.08	-0.28
Long Term Debt Total	0.85	0.76	0.72	0.34	0.63	0.76	0.76	0.88	0.54	0.14	0.77	0.72	0.77	0.98	0.85	0.68	0.81	-0.45	0.78		0.76	-0.19	0.38	0.81	0.31	-0.17
Capital Surpluse	0.85	0.75	0.79	0.21	0.64	0.62	0.72	0.88	0.56	0.54	0.71	0.78	0.59	0.72	0.89	0.89	0.84	-0.8	0.97	0.76		0.15	0.65	0.81	-0.08	-0.33
Short Long Term Debt	0.14	-0.02	0.3	0.03	0.09	-0.31	0.03	0.24	0.19	0.85	0.11	0.12	-0.3	-0.21	0.11	0.22	0.11	-0.53	0.11	-0.19	0.15		0.49	0.26	-0.67	-0.11
Cash And Equivalents	0.55	0.44	0.43	0.24	0.59	0.17	0.42	0.61	0.58	0.61	0.36	0.51	0.45	0.34	0.56	0.69	0.53	-0.75	0.73	0.38	0.65	0.49		0.61	-0.1	-0.31
Net Invested Capital	0.9	0.81	0.77	0.47	0.65	0.58	0.69	0.96	0.69	0.58	0.76	0.7	0.68	0.77	0.88	0.8	0.8	-0.74	0.84	0.81	0.81	0.26	0.61		0.05	-0.25
Net Working Capital	0.22	0.39	-0.4	0.6	0.25	0.39	0.1	-0.04	0.28	-0.7	0.06	0.06	0.64	0.41	-0.09	-0.24	-0.06	0.45	0.08	0.31	-0.08	-0.67	-0.1	0.05		0.54
Capital Stock	0.04	0.14	-0.54	0.55	-0.04	0.06	-0.13	-0.29	0.1	-0.41	-0.09	-0.11	0.05	0.02	-0.49	-0.63	-0.46	0.61	-0.28	-0.17	-0.33	-0.11	-0.31	-0.25	0.54

Click cells to compare fundamentals

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-21.8 M	-20.7 M
Retained Earnings Total Equity	844.1 M	440.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC